RMAT designation enables intensified FDA engagement and potential accelerated pathways, implying preliminary clinical evidence for RTx-015 despite absent peer-reviewed efficacy details, endpoints, and ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted rare pediatric disease designation for OCU410ST, a gene therapy designed to treat ...
Swim Across America, the nonprofit funding innovative clinical trials and patient-centered programs for cancer, is proud to announce the award of two $450,000 grants to two of its beneficiaries, ...
Florida Atlantic University researchers have secured two key grants to investigate targeting a gene for the first time as a new approach to treat glioblastoma, a very aggressive and fast-growing type ...
Please provide your email address to receive an email when new articles are posted on . The designation is intended to expedite the drug development and review process. This is the fourth designation ...
On Thursday, the FDA granted accelerated approval to PTC Therapeutics, Inc.’s (NASDAQ:PTCT) gene therapy for AADC deficiency, the first-ever gene therapy approved in the U.S. that is directly ...
ST. PAUL, Minn., Nov. 7, 2024 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation (TECH) and CellReady, has awarded G-Rex Grants totaling $475,000 to ...
ST. PAUL, Minn., Sept. 9, 2025 /PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (TECH) and CellReady, today announced that eight (8) G-Rex Grants, ...
Revolutionary CRISPR gene editing and other cell and gene therapy editing takes center stage in finding ways to effectively treat cancer “Gene editing, including CRISPR, are some of the most promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results